Today: 7 February 2026
Subscribe
Browse Category

Earnings Reports News 1 February 2026

Novo Nordisk stock heads into earnings week as Wegovy pill scripts top 26,000

Novo Nordisk stock heads into earnings week as Wegovy pill scripts top 26,000

Novo Nordisk Class B shares closed at 369.6 Danish crowns on Friday, down 0.8 crown, as investors awaited the company’s 2025 financial statement set for Feb. 4. U.S. prescriptions for the new Wegovy pill surged to 26,109 in the week ending Jan. 23, up sharply from its launch. Leadership changes in China and rising competition from AstraZeneca add pressure ahead of earnings.
1 February 2026
···
AstraZeneca stock price: NYSE switch, China bets and earnings put AZN in play this week

AstraZeneca stock price: NYSE switch, China bets and earnings put AZN in play this week

AstraZeneca shares closed in London at 135.48 pounds Friday, up 0.65%. The company moves its U.S. listing from Nasdaq to the NYSE on Monday, keeping the AZN ticker. AstraZeneca recently announced a $1.2 billion obesity drug deal with CSPC and pledged $15 billion investment in China by 2030. Investors await full-year results on Feb. 10.
1 February 2026
···
Verizon’s near-12% leap puts communication services stocks in focus ahead of Disney, Alphabet results

Verizon’s near-12% leap puts communication services stocks in focus ahead of Disney, Alphabet results

Verizon surged 11.8% after raising its 2026 profit outlook and announcing a $25 billion buyback. XLC closed at $120.08, up 0.24%, as telecom gains offset losses in internet platforms. AT&T and T-Mobile also rose sharply. The S&P 500 fell 0.43% Friday amid investor focus on Fed leadership and mixed tech earnings.
1 February 2026
·····
Tech stocks brace for Alphabet, Amazon earnings as Nasdaq slip puts AI spending in focus

Tech stocks brace for Alphabet, Amazon earnings as Nasdaq slip puts AI spending in focus

The Nasdaq Composite fell 0.94% Friday to 23,461.82 as tech stocks stumbled ahead of key earnings from Alphabet, Amazon, AMD, and Qualcomm this week. Microsoft dropped 0.7% after a steep cloud revenue miss; Apple rose 0.4% on strong guidance. Investors are watching AI spending and the impact of Kevin Warsh’s Fed nomination as wholesale inflation jumped 0.5% last month.
1 February 2026
·············
Data center stocks slide into packed week as Vertiv, Arista drop; investors eye Big Tech capex

Data center stocks slide into packed week as Vertiv, Arista drop; investors eye Big Tech capex

Vertiv shares fell 4.5% and Arista Networks dropped 4.3% Friday as data center stocks slid ahead of a key week for tech earnings and U.S. economic data. Equinix and Digital Realty Trust also declined, while sector ETFs lost up to 2.5%. The pullback followed higher-than-expected producer prices and news that Donald Trump picked Kevin Warsh for Fed chair. Rising yields pressured REITs and cloud suppliers.
1 February 2026
·········
Microsoft slump sets up a big week for Big Tech stock prices as Alphabet and Amazon report

Microsoft slump sets up a big week for Big Tech stock prices as Alphabet and Amazon report

Apple rose 0.4% to $259.48 Friday, while Tesla jumped 3.3% to $430.41; Microsoft fell 0.7% to $430.29 and Meta dropped 3% to $716.50. Wall Street’s main indexes closed lower after Donald Trump nominated Kevin Warsh as Fed chair and producer prices beat forecasts. Alphabet and Amazon report earnings this week, with the U.S. jobs report due Feb. 6. Investors remain focused on tech guidance and capital spending.
1 February 2026
·······
Semiconductor stocks slide, setting up Advanced Micro Devices and Qualcomm earnings week

Semiconductor stocks slide, setting up Advanced Micro Devices and Qualcomm earnings week

The Philadelphia Semiconductor Index fell 3.9% Friday, closing at 7,998.5, as chip equipment stocks tumbled and KLA Corp dropped 15.2%. Sandisk surged after raising its revenue outlook and extending a supply deal with Kioxia. Investors await earnings from AMD on Feb. 3 and Qualcomm on Feb. 4, along with the U.S. jobs report Feb. 6. President Trump’s nomination of Kevin Warsh for Fed chair weighed on markets.
1 February 2026
·········
Nvidia stock, OpenAI and the AI trade: what to watch before Alphabet and Amazon earnings

Nvidia stock, OpenAI and the AI trade: what to watch before Alphabet and Amazon earnings

Nvidia CEO Jensen Huang called reports of a rift with OpenAI “nonsense” and confirmed plans for a major investment in the company, despite earlier doubts reported by the Wall Street Journal. Nvidia shares closed down 0.7% Friday. Amazon is also in talks to invest up to $50 billion in OpenAI, which is seeking $100 billion in funding. Microsoft, Alphabet, and Amazon shares all ended lower ahead of key earnings reports next week.
1 February 2026
······
Coca-Cola stock price hits a fresh 52-week high — what KO investors watch before Feb. 10 earnings

Coca-Cola stock price hits a fresh 52-week high — what KO investors watch before Feb. 10 earnings

Coca-Cola shares closed at a record $74.81 Friday, up 2% and surpassing last April’s high, as trading volume spiked to 26 million. The rally came amid investor caution over the Fed chair nomination and hotter-than-expected producer-price data. PepsiCo shares rose 3.3%. Coca-Cola reports earnings Feb. 10 and will present at a major investor conference Feb. 17.
1 February 2026
··
Palantir stock braces for Monday earnings after Friday drop as options price in a big swing

Palantir stock braces for Monday earnings after Friday drop as options price in a big swing

Palantir shares fell 3.4% to $146.59 on Friday ahead of its fourth-quarter earnings report set for Monday after the market closes. Options pricing signals traders expect a swing of at least 9% in the stock next week. Analysts forecast record revenue of $1.34 billion and adjusted earnings of $0.23 per share. Investors are focused on guidance for commercial growth and profitability.
1 February 2026
··
AbbVie stock rises into weekend as Feb. 4 earnings loom — what traders watch next

AbbVie stock rises into weekend as Feb. 4 earnings loom — what traders watch next

AbbVie shares closed Friday at $223.01, up 1.2%, outpacing big pharma peers as trading volume topped its 50-day average. The company reports earnings Wednesday, with analysts watching Skyrizi, Rinvoq, and the aesthetics segment. AbbVie’s full-year adjusted earnings guidance stands at $9.90 to $9.94. Investors remain cautious amid macroeconomic uncertainty and upcoming U.S. jobs data.
1 February 2026
··
Mastercard stock price: MA slips after earnings pop as Wall Street braces for jobs report and shutdown risk

Mastercard stock price: MA slips after earnings pop as Wall Street braces for jobs report and shutdown risk

Mastercard shares fell 0.9% to $538.79 Friday, trimming gains from its recent earnings report. U.S. stocks closed lower after President Trump nominated Kevin Warsh to lead the Federal Reserve and amid renewed government shutdown concerns. American Express shares dropped 2% despite issuing a strong 2026 earnings forecast. Mastercard plans to cut about 4% of its global workforce, incurring a $200 million restructuring charge.
1 February 2026
··
1 … 23 24 25 26 27 … 202

Stock Market Today

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
Go toTop